AI
Converge Bio raises $25M to accelerate drug discovery using generative AI solutions
Accelerated drug discovery and development platform Converge Bio Inc. today announced it has raised $25 million in early-stage funding to develop better drugs for pharmaceutical companies and open up opportunities in the industry using…